Sign in →

Test Code QNADL Adalimumab Quantitative, Serum


Specimen Required


Only orderable as part of profile. For more information see ADALP / Adalimumab Quantitative with Antibody, Serum.

 

Patient Preparation: For 12 hours before specimen collection, patient should not take multivitamins or dietary supplements (eg, hair, skin, and nail supplements) containing biotin (vitamin B7).

Collection Container/Tube:

Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.4 mL Serum

Collection Instructions:

1. Draw blood immediately before the next dose of drug administration (trough specimen).

2. Centrifuge and aliquot serum into a plastic vial.

 


Useful For

Therapeutic drug monitoring of adalimumab

 

Quantifying adalimumab as part of a profile evaluating patients for loss of response, partial response on initiation of therapy, autoimmune or hypersensitivity reactions, primary nonresponse, reintroduction after drug holiday, endoscopic/computed tomography enterography recurrence (in inflammatory bowel disease), acute infusion reactions and proactive monitoring

 

This test does not differentiate between the originator and biosimilar products.

 

Method Name

Only orderable as part of a profile. For more information see ADALP / Adalimumab Quantitative with Antibody, Serum.

 

Enzyme-Linked Immunosorbent Assay (ELISA)

Reporting Name

Adalimumab QN, S

Specimen Type

Serum

Specimen Minimum Volume

See Specimen Required

Specimen Stability Information

Specimen Type Temperature Time
Serum Refrigerated (preferred) 28 days
  Frozen  28 days

Reference Values

Only orderable as part of profile. For more information see ADALP / Adalimumab Quantitative with Antibody, Serum.

 

Limit of quantitation is 0.8 mcg/mL. Optimal therapeutic ranges are disease specific.

Day(s) Performed

Monday, Wednesday, Friday

Report Available

2 to 4 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

80145

LOINC Code Information

Test ID Test Order Name Order LOINC Value
QNADL Adalimumab QN, S 86894-3

 

Result ID Test Result Name Result LOINC Value
QNADL Adalimumab QN, S 86894-3